Diabetes Care & Education

Home Sitemap Contact Us FAQs

DCE Journal Review October 2016


1. Improving diet, activity and wellness in adults at risk of diabetes: randomized controlled trial.

Source: http://www.nature.com/nutd/journal/v6/n9/full/nutd201642a.html


Type I Diabetes:

1. Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.

Source: https://cardiab.biomedcentral.com/articles/10.1186/s12933-016-0413-6

2. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial.                                                                                                                                                    

Source: http://www.thelancet.com/journals/landia/article/PIIS2213-8587(16)30193-0/fulltext.

3. Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.

Source: http://jama.jamanetwork.com/article.aspx?articleid=2552454.

4. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.                                                                                          

Source: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)31535-5/fulltext.

5. Serum Fatty Acid Binding Protein 4 (FABP4) Predicts Pre-Eclampsia in Women With Type 1 Diabetes.

Source: http://care.diabetesjournals.org/content/early/2016/08/09/dc16-0803.

Type II Diabetes:

1. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes.

Source: http://www.jdcjournal.com/article/S1056-8727(16)30458-5/fulltext.

2. Severe Periodontitis is Associated with Insulin Resistance in Non-Abdominal Obese Adults.

Source: http://press.endocrine.org/doi/abs/10.1210/jc.2016-2061.

3. Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial.

Source: http://www.thelancet.com/journals/landia/article/PIIS2213-8587(16)30267-4/fulltext

4. Changes in Overall Diet Quality and Subsequent Type 2 Diabetes Risk: Three U.S. Prospective Cohorts.

Source: http://care.diabetesjournals.org/content/early/2016/09/09/dc16-0574.

5. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial.

Source: http://care.diabetesjournals.org/content/early/2016/09/09/dc16-1495.


Pediatric Diabetes:

1. Evidence for energy conservation during pubertal growth A 10-year longitudinal study (EarlyBird 71).

Source: http://www.nature.com/ijo/journal/vaop/naam/abs/ijo2016158a.html.

2. Harnessing adolescent values to motivate healthier eating.

Source: http://www.pnas.org/content/early/2016/09/06/1604586113.

3. Changes in Moderate-to-Vigorous Physical Activity Among Older Adolescents.

Source: http://pediatrics.aappublications.org/content/early/2016/09/22/peds.2016-1372.

Gestational Diabetes:

1. A longitudinal study of depression and gestational diabetes in pregnancy and the postpartum period                                                                                                                  

Source: http://link.springer.com/article/10.1007%2Fs00125-016-4086-1

2. Regular exercise to prevent the recurrence of gestational diabetes mellitus: A randomized controlled trial.

Source: http://www.mdlinx.com/obstetrics-gynecology/medical-news-article/2016/09/29/gestational-diabetes-mellitus/6874344/.

Metabolic Syndrome:

1. Increased liver fat and glycogen stores following high compared with low glycaemic index food: a randomized cross over study.

Source: http://onlinelibrary.wiley.com/doi/10.1111/dom.12784/abstract.

2. Sugar Industry and Coronary Heart Disease Research.

Source: http://archinte.jamanetwork.com/article.aspx?articleid=2548255.

3. High Stress and Negative Health Behaviors: A Five-Year Wellness Center Member Cohort Study.

Source: http://journals.lww.com/joem/Fulltext/2016/09000/High_Stress_and_Negative_Health_Behaviors_A.3.aspx

4. Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight LossThe IDEA Randomized Clinical Trial.                                                                        

Source: http://jama.jamanetwork.com/article.aspx?articleid=2553448.


5. Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association.    

Source: http://circ.ahajournals.org/content/early/2016/09/19/CIR.0000000000000444


Diabetes Management:

1. Short-Term Effects of Laparoscopic Adjustable Gastric Banding Versus Roux-en-Y Gastric Bypass.

Source: http://care.diabetesjournals.org/content/early/2016/08/26/dc15-2823.

2. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: a 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

Source: http://care.diabetesjournals.org/content/early/2016/08/31/dc16-1371.

3. Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.

Source: http://onlinelibrary.wiley.com/doi/10.1002/oby.21533/abstract.

4. Practice-Level Variation in Statin Use Among Patients With Diabetes.

Source: http://content.onlinejacc.org/article.aspx?articleID=2552333.

5. Diabetes Mellitus Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials.

Source: http://care.diabetesjournals.org/content/early/2016/09/08/dc16-0850.